Stoke’s ASO therapy is designed to raise the protein to normal levels. “These data are particularly exciting because this approach could lead to the first disease-modifying treatment for patients with Dravet Syndrome. Stoke is also working on applying … (본문 전체 12/2/2018 8:49 PM)